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1MB-S prevents the hydroosmotic response to ADH in rabbit cortical
collecting tubules. Both AVP and dDAVP effect a transient increase in
cytosolic free calcium (iCa2) in cortical collecting tubule (CCT) cells.
To investigate the physiological role of this increase in iCa2, we
examined the effect of TMB-8, a putative inhibitor of iCa2'1' release, on
the initial and sustained phase of AVP- and dDAVP-stimulated water
permeability (Pt') in isolated, perfused CCTs. Pretreatment of tubules
with TMB-8, 50 tiM, suppressed the increase in osmotic water perme-
ability (Pt) induced by 10 U/ml AVP and dDAVP, but had no effect on
the sustained phase of the response. When increased to 100 M, TMB-8
inhibited the sustained phase of AVP action. A similar pattern was
observed on AVP-stimulated adenylyl cyclase activity in rabbit renal
membranes. Pretreatment of tubules with 50 sM TMB-8 attenuated the
initial increase in Pf in response to cholera toxin but not to 8-Br-cAMP
or forskolin. There was no effect of this concentration of TMB-8 on the
sustained phase of these agonists. These studies suggest that, in lower
concentrations, TMB-8 inhibits the mobilization of iCa2, which is
important for the interaction of Gs with the catalytic unit of adenylyl
cyclase and the initial increase in AVP-stimulated Pf. In higher concen-
trations, TMB-8 inhibits adenylyl cyclase activity directly,
Previous studies have shown that arginine vasopressin (AVP)
causes a transient increase in cytosolic free calcium (Ca2) in
LLC-PK1 cells [1], rat inner medullary [21, and papillary
collecting tubule cells [3] and rabbit cortical collecting tubule
(CCT) cells [4]. Two studies also have demonstrated an in-
crease in cytosolic Ca2' using dDAVP, the V2 selective ana-
logue of AVP, which would not have been expected to activate
a calcium release mechanism [5, 61. The role this phenomenon
plays in the hydroosmotic response to the hormone is not
known, but has been the subject of a number of investigations.
Several studies have examined the effect of altering extracellu-
tar and/or cytosolic Ca2 on the hydroosmotic response to AVP
[7—12]. However, the results of these studies have been con-
flicting. Both Goldfarb [7] and Dillingham, Dixon, and Ander-
son [8], using rabbit CCT perfused in vitro, reported that
increasing the extracellular calcium concentration stimulates
the hydroosmotic response to ADH. Conversely, the polyuria
which accompanies hypercalcemic states has led several inves-
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tigators to invoke a suppressive effect of high serum Ca2 on
the action of ADH, interfering with either the interaction of
ADH with its receptors or the activation of the intracellular
message mechanisms [9, 101. Studies in toad urinary bladder
epithelium showed that increasing serosal Ca2 inhibited the
action of vasopressin, presumably by preventing cyclic AMP
generation [13]. Increasing cytosolic Ca2 with the ionophores,
A23187 and ionomycin, inhibits both the initiation and mainte-
nance phases of AVP-stimulated osmotic water permeability in
rabbit cortical collecting tubules [11, 12]. However, Jones,
Frindt, and Windhager [12] also showed that the initial response
to AVP was blunted in tubules pretreated with Quin 2-AM, in
concentrations that effectively buffer increases in cytosolic
Ca2. This observation suggests that an increase in cytosolic
calcium is necessary for the initiation of the hydroosmotic
action of AVP.
There are several possible explanations for the apparent
discrepancies among the above studies. An agonist effect of
Ca2 may be attributed to activation of the Ca2-calmodulin
sensitive protein kinase [14—16]. An antagonist effect may be
attributed to stimulation of prostaglandin synthesis [17—2 1] or
activation of protein kinase C [22, 23]. Each of these biochem-
ical reactions may be activated by different concentrations or
different sources of cytosolic Ca2t
In the present study, we have investigated the effect of
TMB-8, a putative inhibitor of intracellular calcium mobiliza-
tion or availability [24—28], on the hydroosmotic response to
AVP and the V2-selective analogue, dDAVP, in isolated corti-
cal collecting tubules (CCT) perfused at 38°C. We have also
investigated the step at which the effect of TMB-8 is exerted in
the adenylyl cyclase cascade in perfused tubules. Finally, we
have examined the effect of TMB-8 on AVP-stimulated cyclic
AMP generation in a crude membrane preparation of the whole
kidney.
Methods
Effect of TMB-8 on hydroosmotic response
General. Female New Zealand white rabbits weighing 1.5 to
2.5 kg were killed by injection of T-6l Euthanasia solution
(Hoechst-Roussel Co., Somerville, New Jersey, USA). The left
kidney was rapidly removed, decapsulated and sliced for dis-
section and microperfusion of CCT segments according to the
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method of Burg et al 129]. The tubules were dissected in an
ice-chilled glass dish containing bath solution with the following
composition (in mmol/liter): NaCl, 115; NaHCO3, 25; K2HPO4,
2.5; MgSO4, 1.2; L-alanine, 6.0; Na citrate, 1.0; Na lactate, 4.0;
CaCI2, 1.8; and glucose, 5.5; bovine serum albumin was added
to a final concentration of 0.25 g/dl. The pH was maintained at
7.4 by gassing with 5% CO2 and 95% 02; the osmolality was 290
m0sm/kg H20. Segments of CCT were transferred to a ther-
mostatically controlled Lucite chamber and bathed with the
solution described above, which was exchanged continuously
at 0.5 ml/min and maintained at 38°C. The tubule segments were
cannulated and perfused as previously described [30]. The
perfusion solution had the following composition (in mmoi/
liter): NaCI, 60; K,HPO4, 2.5; MgSO4, 1.2; and CaCl2, 1,8. The
pH was 6.2 and the osmolality was 125 m0sm/kg H20. Exhaus-
tively dialyzed [methoxy-3H]inulin (ICN, Irvine, California,
USA), was added to the perfusion solution as a volume marker.
The perfusate was driven by a gravity flow system at a rate of
8 to 12 nI/mm. To avoid possible effects of endogenous vaso-
pressin, an equilibration period of 90 minutes was allowed after
the initiation of perfusion. After this period, samples were
collected using constant-volume pipettes, placed in counting
vials containing 10 ml of Biofluor (New England Nuclear,
Boston, Massachusetts, USA) and the radioactivity measured
in a liquid scintillation counter (Packard Instrument Co. Inc.,
Downers Grove, Illinois, USA).
Arg8-vasopressin (AVP) acetate, 8-(N ,N-diethylamino)-oc-
tyl-3 ,4,4-trimethoxybenzoate hydrochloride (TMB-8), and
8-bromo-cyclic adenosine monophosphate (8-Br-cAMP) were
obtained from Sigma Chemical Co. (St. Louis, Missouri, USA),
forskolin from Calbiochem (San Diego, California, USA), chol-
era toxin from List Biological Laboratories (Campbell, Califor-
nia, USA), and l-/3mercaptopropionic acid 8-D arginine vaso-
pressin (dDAVP) was a gift from Rorer Pharmaceuticals Corp.
(Fort Washington, Pennsylvania, USA). A 10 m stock solu-
tion of TMB-8 was prepared in a buffer solution [31] of the
following composition (in mmol/liter): NaCI, 136; Tris-HCI (pH
7.4), 25; glucose, 5, and kept frozen between experiments.
Immediately prior to use, TMB-8 was added to the bathing
medium to a final concentration of 50 M.
Calculations. Osmotic permeability, Pf, (cm/sec) was calcu-
lated by the following formula:
ViCi Ci — Co I (Co — Cb)(Ci)Pf= — +—ln----AVw CiCbCo (Cb)2 (Ci — Cb)(Co)
where Vi is the tubular fluid perfusion rate in nI/mm, calculated
from the 3H-inulin concentration as described previously [30];
A, the area of the tubule (cm2); Vw, the partial molal volume of
water (cm3/mmol); and Ci, Cb and Co. the osmolality of the
perfusate, bath and collected fluid (mosmlkg), respectively. Ci
and Cb were measured directly on an Advanced Instruments
(Needham Heights, Massachusetts, USA) osmometer. Co was
calculated from the relationship: ([3Ho]/[3Hi]) x (Ci), where
3Ho and 3Hi are the inulin disintegrations per minute per
nanoliter for the collected and perfused fluid, respectively.
Protocols. Four to five collections, each approximately five
minutes long, were made immediately following the initial
equilibration period to determine a mean control Pf value. The
subsequent experimental collections were also made in groups
of four to five.
Effect of TMB-8, 50 ' on basal Pf
In two tubules from Group 4 and two from Group 9, following
control collections, TMB-8 was added to the bathing solution
and after 10 minutes, further collections made to determine the
effect of TMB-8 on basal Pf.
Effect of TMB-8 on agonist-stimulated Pf
1) TMB-8 and AVP. (a) Post-treatment with 50 JiM TMB-8
(Group I). Following control collections, AVP 10 JiU/ml was
added to the bath and after 40 minutes, additional collections
made. TMB-8, 50 JiU/ml, was then added to the bath containing
AVP, 20 minutes allowed and final collections made.
(h) Post-treatment with 100 JiM TMB-8 (Group 2). The
protocol for this group was identical to Group I, except that the
concentration of TMB-8 was increased to 100 JiM.
(c) Pretreatment with TMB-8 (Group 3). Following control
collections, TMB-8 (50 LM) was added to the bath. After 20
minutes, AVP (10 JiU/ml) was added to the bath containing
TMB-8, 40 minutes allowed and final collections made.
2) TMB-8 and dDAVP. (a) Post-treatment with TMB-8
(Group 4). The protocol for this group was identical to Group 1
except that dDAVP (10 tU/ml) was added to the bath instead of
AVP.
(b) Pretreatment with TMB-8 (Group 5). The protocol for this
group was identical to Group 3 except that dl)AVP (10 JiU/ml)
was added to the bath instead of AVP. In two experiments, four
collections were made following the addition of TMB-8, such
that dDAVP was added after 30 minutes of exposure to TMB-8.
3) TMB-8 and 8-Br-cAMP. (a) Post-treatment with TMB-8
(Group 6). The protocol for this group was identical to Group I
except that 8-bromo-cyclic AMP (100 JiM) was added to the
bath instead of AVP.
(h) Pretreatment with TMB-8 (Group 7). The protocol for this
group was identical to Group 3 except that 8-bromo-cyclic AMP
(100 JiM) was added to the bath instead of AVP.
4) TMB-8 and forskolin. (a) Time control (Group 8). Previous
studies have shown that the hydroosmotic effect of forskolin
declines after 40 minutes in tubules studied at 38°C 32]. Since
these protocols require 90 to 100 minutes of exposure to the
agonists, a time control study was performed. Following con-
trol collections, forskolin (100 JiM) was added to the bath, 40
minutes allowed and further collections made. Final collections
were made after 90 minutes of exposure to this agonist.
(h) Post-treatment with TMB-8 (Group 9). The protocol for
this group was identical to Group 1 except that forskolin (100
/.LM) was added to the bath instead of AVP.
(c) Pretreatment with TMB-8 (Group 10). The protocol for
this group was identical to Group 3 except that forskolin (100
JiM) was added to the bath instead of AVP. In two experiments,
collections were made following the addition of TMB-8, such
that forskolin was added after 30 minutes of exposure to
TMB-8.
5) TMB-8 and cholera toxin. (a) Post-treatment with TMB-8
(Group 11). Following control collections, cholera toxin (1 nM)
was added to the bath, 90 minutes allowed and further collec-
tions made. TMB-8 was then added to the bath containing
cholera toxin, 20 minutes allowed and final collections made.
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(b) Pretreatment with TMB-8 (Group 12). Following control
collections, TMB-8 (50 j.M) was added to the bath, 20 minutes
allowed and further collections made. Cholera toxin (I nM) was
then added to the bath containing TMB-8, 90 minutes allowed
and final collections made. The 90-minute equilibration period
for cholera toxin is the time necessary for its maximal effect to
be exerted [321.
Statistics
All values are expressed as the mean SEM. Comparisons
among the values were made using Student's 1-test, paired
t-test, or analysis of variance where appropriate. The values
were considered significantly different if P < 0.05.
Effect of TMB-8 on adenylyl cyclase
The sources of the materials used for the adenylyl cyclase
assays were as previously described [33] except that the
[cs-32P]ATP, synthesized by the procedure of Walseth and
Johnson [34], was supplied to us by the Molecular Endocrinol-
ogy Core Laboratory of the Baylor College of Medicine Diabe-
tes and Endocrinology Research Center.
The contralateral kidney of rabbits used for microperfusion
experiments was rapidly removed and placed in ice-cold Krebs-
Ringer bicarbonate buffer, pH 7,4. All subsequent procedures
were done on ice. The kidneys were decapsulated, minced and
homogenized in 20 volumes of 1 mM KHCO1 in a Dounce
homogenizer with 10 strokes of the loose pestle followed by 10
strokes of the tight pestle. The resulting homogenate was
filtered through #12 Japanese silk screen. The filtered homoge-
nate was subjected to two consecutive centrifugations at 4°C.
The first centrifugation (5 mm, at 160 x g) removed tissue
fragments, nuclei and major cell debris. The second centrifuga-
tion (30 mm, at 10,000 x g), carried out in a SS-34 rotor of the
Sorval RC-5B centrifuge, concentrated membrane particles
contained in the supernatant fluid after the first centrifugation.
The resulting pellet was resuspended in 1 mM KHCO3 (5
volumes with respect to original tissue weight) with theaid of a
syringe affixed with a 20 gauge needle.The resulting particulate
preparation was distributed in 0.2 ml aliquots, quick frozen in
test tubes (10 x 75 mm) on dry ice and acetone, and stored at
—70°C until used. Protein content of membranes was deter-
mined by the method of Lowry et al [35].
Adenylyl cyclase activity was determined at 32.5°C for 10
minutes in 50 d of medium containing 10 .d of membrane
preparation (approximately 15 g protein), 0.1 mtvi ATP (with 3
to 5 x 106 CPM of[a-32P]ATP), 3.0 mi MgCl2, 1.0 mt EDTA,
1.0 mM cAMP (with approximately 10,000 CPM of [3H] cAMP,
20 m'i creatine phosphate, 0.2 mg/mI creatine kinase, 0.02
mg/mI myokinase and 25 m Tris-HCI, pH 7.5. Adenylyl
cyclase was stimulated with GMP-P(NH)P (25 tiM), or with
AVP (10—6 M) and GTP (25 SM). As controls, cyclase was
assayed with no added agonist or with 25 iM GTP alone.
TMB-8 was added to the assay mixture in concentrations
ranging from 0 to 10 m. Assays were stopped by the addition
of 100 d of "stopping solution" consisting of 10 mrt cAMP, 40
mM ATP, and 1% SDS. The [32P]cAMP formed and the
[3H]cAMP added to monitor recovery were isolated using
Dowex and alumina chromatography according to the method
of Salomon, Londos, and Rodbell [36]. All experiments were
Control
AVP and TMB-8, 50 LM
Post 2.0 8.6 199.7 5.3 183.8 11.0
Pre —2.2 2.8 50.9 11.6°'
AVP and TMB-8, 100 M
Post 7.3 7.5 228.4 56.0 73.0 169a.b
dDAVP and TMB-8, 50
Post 10.1 3.8 224.8 14.0 213.8 12.2
Pre —3.1 2.8 26.0 13,1b
repeated a minimum of three times with similar results and
representative experiments are presented.
Results
Microperfus ion studies
Effect of TMB-8 (50 M) on baseline Pf (N = 4). In these
experiments, collections were made after the addition of TMB-8
to determine its effect on basal Pf. Vi was 10.9 0.7 before and
10.1 0.3 nI/mm after the addition of TMB-8 to the bathing
solution. Pf was also unchanged, being —0.1 3.3 before and
—4.6 6.8 x l0— cm/sec after exposure to TMB-8.
Effect of TMB-8 on agonist-stimulated Pf.' 1) TMB-8 and
A VP.
(a) Post-treatment with TMB-8 50 r.tM (N = 5, Group 1). In
this group of CCTs (mean length, 1.2 0.1 mm) Vi increased
significantly from 10.7 0.2 nI/mm to 13.1 0.3 after the
addition of AVP and remained increased with the addition of
TMB-8, being 12.8 0.4 nI/mm. Although Vi is higher in the
latter two periods of collection, the increase cannot account for
the magnitude of increase in Pf in these periods [37]. Pf
increased significantly with the addition of AVP to the bath and
was unaltered by the subsequent addition of TMB-8 (Table 1).
Time control studies with AVP were recently published in
which we demonstrated that AVP-stimulated Pf is sustained for
at least 180 minutes at 38°C [38]. A second set of tubules was
studied in an identical manner except that a fourth set of
collections was made after 60 minutes exposure to TMB-8. In
this group of four tubules, Pf was 16.1 10.2 x i0 cm/sec in
control, 225.4 49.4, following the addition of 10 .tU/ml AVP,
263.8 42.8 after 30 minutes of exposure to 50 tM TMB-8, and
257.9 53.1 after 60 minutes of exposure to TMB-8. In other
words, TMB-8 failed to inhibit Pf even after an extended period
of exposure.
(b) Post-treatment with TMB-8 100 ItM (N = 4, Group 2). In
this group of tubules (mean length, 2.6 0.4 mm), Vi was 10.5
0.4 nI/mm, for control, increased to 15.4 1.1 after the
addition of 10 iU/ml AVP, and remained high (12.2 0.5) after
the addition of TMB-8, 100 /.LM, to the bathing solution. Pf
increased following the addition of AVP and was significantly
inhibited with the subsequent addition of 100 tM TMB-8. A
qualitatively similar pattern was seen in another set of experi-
ments where a submaximal concentration of AVP, 1 iU/ml,
was used to stimulate Pf. In these experiments, the addition of
Table 1. Effect of post-treatment and pretreatment with TMB-8 on






° Significantly different from post-agonist Pf
b Significantly different from post-agonist + TMB-8 Pf
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Table 2. Effect of post-treatment and pretreatment with TMB-8,








8-Br cyclic AMP and TMB-8
Post 5.8 3.7 237.6 33.3 241.2 48.9
Pre 5.0 1.0 242.0 25.5
Forskolin and TMB-8
Post 15.3 9.0 342.8 39.0 271.4 30.1
Pre 6.6 2.9 246.7 28.8
Cholera toxin and TMB-8
Post 10.1 6.7 268.8 9.7 283.6 15.0
Pre 3.7 5.7 92.8 39.2""
Significantly different from post-agonist Pf
b Significantly different from pre-agonist + TMB-8 Pf
20 iM TMB-8 failed to inhibit the sustained phase. however,
when the concentration of TMB-8 was increased to 50 ILM, Pf
was significantly decreased (23.2 4.5 x l0 cm/sec vs. 68.1
12.6 in tubules not treated with TMB-8, P < 0.02).
(b) Pretreatment with TMB-8 (N = 4, Group 3). In this group
of CCTs (mean length, 1.1 0.2 mm), Vi was 11.0 0.7 nI/mm
before and 12.0 0.7 after the additions of TMB-8 and AVP to
the bathing solution (P = 0.5). Following pretreatment with 50
LM TMB-8, the addition of AVP increased Pf significantly
above baseline, but Pf was significantly lower than that ob-
tained with AVP alone or AVP + TMB-8 in group I (Table I).
2) TMB-8 and dDAVP: (a) Post-treatment with TMB-8 (N =
4, Group 4). In this group of CCTs (mean length, 1.4 0.3 mm),
Vi increased significantly from 10.8 0.9 nI/mm to 13.2 0.3
following the addition of dDAVP, and remained increased (13.3
0.6) with the addition of TMB-8. Pf increased significantly
with the addition of dDAVP and was unaltered by the subse-
quent addition of 50 iM TMB-8 (Table I). We have previously
shown that 10 tU/ml dDAVP effects a Pf similar to 10 tU/mI
AVP, and its effects also are sustained for at least 180 minutes
at 38°C [38].
(b) Pretreatment with TMB-8 (N =4, Group 5). In this group
of tubules (mean length, 1.1 0.4 mm), Vi was 11.0 0.6
nI/mm before and 11.0 0.4 after the additions of TMB-8and
dDAVP to the bath (P = 0.9). Pf increased significantly follow-
ing the additions of TMB-8 and dDAVP, however, this value
was significantly lower than the Pf measured after the addition
of dDAVP or dDAVP + TMB-8 in Group 3 (Table 1).
(3) TMB-8 and 8-Br-cAMP: (a) Post-treatment with TMB-8
(N = 4, Group 6). In this group of tubules (mean length, 1.4
0.2 mm), Vi was unchanged among the collection periods, being
10.7 0.6 nI/mm, control, 13.9 0.9 after the addition of 8-Br
cyclic AMP, and 12.6 1.3 after the addition of TMB-8. Pf
increased significantly after the addition of 100 tM 8-Br cyclic
AMP and was unchanged with the subsequent addition of 50 jM
TMB-8 (Table 2).
(b) Pretreatment with TMB-8 (N = 4, Group 7). In this group
of CCTs (mean length, 1.4 0.1 mm), Vi was 10.7 0.4 before
and 13.2 0.3 after the additions of 8-Br cyclic AMP (P =
0.03). Pf increased significantly, following the additions of
TMB-8 and 8-Br cyclic AMP, to a value not different from the
Pf value after the addition of 8-Br cyclic AMP or cyclic AMP +
TMB-8 in group 5 (Table 2).
(4) TMB-8 and forskolin: (a) Time controls with forskolin (N
= 6, Group 8). In these CCTs (mean length, 1.0 0.2 mm) Vi
was unchanged among the three collection periods, being 10.3
0.3 nI/mm, control, 13.0 1.3, first collection period after
forskolin addition, and 12.2 1.4, second collection period
after forskolin. Pf increased from 15.2 2.8 x l0— cm/sec to
337.9 56.4, after 40 minutes of exposure to 100 LM forskolin.
After 90 minutes of exposure to forskolin Pf was 239.9 70.8 x
IO cm/sec. a value numerically but not significantly lower
than that observed after 40 minutes of exposure.
(b) Post-treatment with TMB-8 (IV 5, Group 9). In this
group of tubules (mean length, 1.4 0.2mm), Vi was 11.3 0.6
ni/mm during control, increased significantly to 13.8 0.7
following the addition of forskoiin, and was 12.9 0.6 after the
addition of TMB-8, a value not significantly different from
control or forskolin values. Pf increased significantly following
the addition of 100 M forskolin and was not significantly
altered by the addition of 50 jiM TMB-8 (Table 2). The Pf
following TMB-8 addition was numerically, but not statistically,
lower than that with forskolin alone, and was statistically the
same as the Pf observed after 90 minutes of exposure to
forskolin alone (Group 7),
(C) Pretreatment with TMB-8 (N =5, Group 10). In this group
of tubules (mean length, 1.0 0.1 mm), Vii was significantly
higher after the addition of TMB-8 and forskolin versus control,
being 11.0 0.6 and 13.1 0.6 nI/mm. respectively. Pf
increased significantly following pretreatment with TMB-8 and
the addition of forskolin, to a value not different from that
observed following the addition of forskolin or forskolin +
TMB-8 (Group 8) (Table 2).
5) TMB-8 and cholera toxin: (a) Post-treatment with TMB-8
(N = 5, Group II). In this group of CCT's (mean length, 1.3
0.2), Vi increased from 10.4 0.3 nI/mm to 13.9 0.9 following
the addition of cholera toxin, and remained increased after the
addition of TMB-8, being 13.9 0.6. Pf increased significantly
with the addition of 1 n cholera toxin and was unchanged by
the subsequent addition of 50 jiM TMB-8 (Table 2).
(h) Pretreatment with TMB-8 (N =7, Group 12). In this group
of tubules (mean length, 1.1 0.1 mm), Vi was 10.4 0.5
nl/min before and 11.4 0.6 after the additions of TMB-8 and
cholera toxin (P = 0.2). Pf increased to 92,8 39.2 x iO
cm/sec following the additions of TMB-8 and cholera toxin.
This value is significantly lower than that observed with cholera
toxin or cholera toxin + TMB-8, Group 10 (Table 2). Since
these tubules were exposed to TMB-8 for a period of 90 minutes
and the longer exposure itself may account for the decrease in
Pf, the value also was compared to AVP-stimulated Pf after 90
minutes exposure to TMB-8 and found to be significantly lower
(92.8 39.2 x l0— cm/sec vs. 257.9 53.1; see TMB-8 and
AVP, post-treatment).
Effect of TMB-8 on adenylyl cyclase activity in renal
membranes
Adenylyl cyclase activity, expressed as pmol of cyclic AMP
produced per mm per mg of protein, is shown in Figure 1. Both,
AVP and GTP, and GMP-P(NH)P stimulated adenylyl cyclase.
TMB-8 in concentrations of 100 jiM and higher progressively









Fig. 1. Effect of TMB-8 on adenylyl c clase activity in renal inern-
branes. Symbols are: (•) GMP-P(NH)P; (U) AVP + GTP: (U) GTP;
(0) control. Beginning at a concentration of 0.1 mr'i TMB-8 progres-
sively inhibits adenylyl cyclase activity when it had been stimulated by
GMP-P(NH)P or by AVP and GTP. The half-maximal inhibitory
concentrations (IC50) are shown.
inhibited cyclase activity, with a half-maximal inhibitory con-
centration (IC50) of 440 M in the presence of AVP and GTP,
and of 1.54 mivi in the presence of GMP-P(NH)P. At a concen-
tration of 50 M, the concentration used in intact tubules,
TMB-8 had little effect on adenylyl cyclase activity.
Discussion
Previous studies, using fluorescent dyes, have shown a rapid
and transient increase in cytosolic Ca2 after stimulation by
AVP in LLC-PK1 cells [39, 401, cortical collecting tubules [41],
inner medullary collecting duct [5], and papillary collecting
tubule cells [6]. An increase in cytosolic Ca24 has also been
observed using dDAVP, the V2 selective analogue, which
purportedly only stimulates adenylyl cyclase activity [5, 6].
There are several possible interpretations of this seemingly
discrepant observation. Firstly, dDAVP may have had some
unrelated VI receptor agonist activity in these studies, and
indeed, Burnatowska-Hledin and Spielman [39, 41] could not
demonstrate this transient elevation in cytosolic Ca24 following
the addition of dDAVP in LLC-PK1 and CCT cells, The
changes in cytosolic Ca2 caused by AVP and dDAVP, there-
fore, may be irrelevant to the hydroosmotic response. Alterna-
tively, the hydroosmotic response to AVP and dDAVP, in
CCTs, does involve an increase in cytosolic Ca24.
In the present study, pretreatment of CCTs with 50 LM
TMB-8, a putative inhibitor of cytosolic Ca24 mobilization,
inhibits the initiation of the hydroosmotic response when added
prior to the addition 10 cU/ml AVP and dDAVP (pretreatment).
This concentration of TMB-8 had no effect on the sustained
phase of the response to AVP or dDAVP when added after the
hydroosmotic response had become established (post-treat-
ment). However, 100 /LM TMB-8 did inhibit the sustained phase
of the hydroosmotic response to AVP. The same pattern was
observed when Pf was stimulated with a submaximal concen-
tration of AVP. In these studies, 20 M TMB-8 did not inhibit
the sustained phase of the response to I iU/ml AVP; however,
50 /.LM TMB-8 was inhibitory.
These results suggest that TMB-8 has different mechanisms
of action depending on the concentration used, and that higher
concentrations inhibit adenylyl cyclase after agonist stimula-
tion. When used as a pretreatment, the lower concentration
may inhibit the mobilization of cytosolic Ca24 which may be
crucial for the initiation of the hydroosmotic response to AVP
and dDAVP, but may not be required for the sustained phase.
The inhibition of the sustained phase by higher concentrations
may indicate a direct inhibition of adenylyl cyclase activity.
Consistent with the above interpretation is one observation in
the study by Jones, Frindt, and Windhager [121. Using isolated
perfused CCT, these investigators found that when an increase
in cytosolic Ca24 was prevented, by pretreatment with Quin
2-AM and incubation in a low Ca24 medium, the initiation
phase of the hydroosmotic response to AVP was inhibited. The
same investigators also have shown that calcium ionophores,
added before or after AVP or CIPheS-cyclicAMP, inhibited the
hydroosmotic response to these agonists [12]. In another study,
they found that quinidine, a substance thought to increase
cytosolic Ca24 by inhibition of active sodium transport and the
Na4/Ca24 exchanger, also inhibits both the initial and sustained
phase of the hydroosmotic response to AVP and a cyclic AMP
analogue [42]. This latter study is consistent with an inhibitory
role of cytosolic Ca2 at a step distal to cyclic AMP formation.
These apparently contrasting results may be explained by the
magnitude of the rise in cytosolic Ca24 concentration effected
by the different maneuvers and/or the cytosolic processes that
are activated or suppressed. A small, transient increase in
cytosolic Ca24 may activate the Ca24-calmodulin sensitive
protein kinase which may have an agonist effect [14—l6], while
larger and more sustained increases may stimulate prostaglan-
din synthesis or activate protein kinase C, both known to inhibit
the action of AVP [17—21]. Consistent with this notion is the
recent study by Ishikawa and Saito [43]. Using papillary col-
lecting tubules, these investigators demonstrated that the max-
imal cyclic AMP production, in response to AVP, required
cytosolic Ca24 concentrations of 91 to 162 nM. When cytosolic
Ca24 was lowered to 50 nrvi or less or increased to 600 nM or
greater, cyclic AMP production was depressed. Together, our
results and those of others suggest that an initial increase in
cytosolic calcium is necessary for the development of the
hydroosmotic response to AVP.
To localize the step in the second messenger system at which
cytosolic Ca24 may be required we studied the effect of pre- and
post-treatment with TMB-8 on the hydroosmotic effect of
cholera toxin, forskolin, and cyclic AMP. TMB-8 had no effect
on the sustained phase of the hydroosmotic response to any of
these agonists or the initiation phase induced by forskolin or
0 0.01 1 10
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cyclic AMP. The initiation of the hydroosmotic response to
cholera toxin, however, was significantly depressed by TMB-8
pretreatment. These results suggest that TMB-8 interferes with
either the binding of GTP to guanine nucleotide stimulatory
protein (G) or the activation of the catalytic unit of adenylyl
cyclase by this regulatory protein.
In previous studies, the hormone concentrations needed for
the detection of a transient calcium peak were three to five
orders of magnitude higher than those sufficient for the devel-
opment of the hydroosmotic response in our studies. This raises
a question of whether the increase in cytosolic Ca2 is a
physiologic or pharmacologic effect of AVP. If an increase in
cytosolic Ca2 is not a physiologic effect of AVP, a different
mechanism will have to be invoked for the inhibition, by
TMB-8, of the initiation of the hydroosmotic action of AVP.
The most obvious possibility is that TMB-8 may inhibit adenyl-
yl cyclase, directly. To explore this possibility, we have inves-
tigated the effect of TMB-8 on adenylyl cyclase activity in
rabbit renal membranes. TMB-8 did inhibit cyclase activity
stimulated by saturating concentrations of AVP and GMP-
P(NH)P. Using these high concentrations of agonists, the IC90
for AVP-stimulated cyclase activity was eightfold higher than
that used as a pretreatment in microperfused tubules and
twofold higher than the concentration which was toxic to our
isolated perfused tubules. At concentrations of 50 and 100 jsM,
TMB-8 had little or no effect on AVP-stimulated cyclase
activity. One might argue that higher concentrations of TMB-8
are necessary to inhibit the higher concentrations of agonists
used in this experiment. However, using this reasoning, 50 M
TMB-8 should have been sufficient to inhibit both the initiation
and sustained phases of the hydroosmotic response to 10 pi.J/mI
(or l0 M) AVP. Imbert et al [44] have shown that this
concentration of AVP stimulates cyclase activity in CCT only
twofold above baseline while it maximally stimulates Pf in
isolated, perfused tubules [30]. We suggest that it is more likely
that TMB-8, in lower concentrations, inhibits the activation of
a cellular event that is crucial for the full expression of AVP
action, and that this event involves the mobilization of cytosolic
Ca2. In higher concentrations, TMB-8 may inhibit adenylyl
cyclase directly.
The cytosolic Ca2 transients observed following addition of
pharmacological concentrations of AVP and dDAVP may rep-
resent either an exaggeration of events taking place at physio-
logical concentrations or an unrelated process. It is possible
that the concentration of AVP necessary for the maximal
hydroosmotic response also increases cytosolic Ca2 to a
concentration that activates a cellular event, but is not detect-
able by present techniques used to measure Ca2. Our results,
coupled with the current notion of the action of TMB-8, are
consistent with this latter explanation.
In summary, this study demonstrates that TMB-8 inhibits the
initiation of the hydroosmotic effect of AVP, by interfering with
the activation of the guanine nucleotide stimulatory protein (G)
and/or the activation of adenylyl cyclase by this regulatory
protein. We suggest that a transient increase in cytosolic Ca2,
effected by AVP, enhances the activation of Q and/or the
subsequent Ga-dependent reactions and is crucial for the full
expression of the hydroosmotic action of AVP.
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